{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "POOLBEG PHARMA  LS -,0002", "longName": "Poolbeg Pharma PLC", "messageBoardId": "finmb_718912342", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.074, "marketState": "REGULAR", "sharesOutstanding": 500000000, "bookValue": 0.037, "fiftyDayAverage": 0.07901, "fiftyDayAverageChange": -0.0050100014, "fiftyDayAverageChangePercent": -0.06340971, "twoHundredDayAverage": 0.0714075, "twoHundredDayAverageChange": 0.002592504, "twoHundredDayAverageChangePercent": 0.036305767, "marketCap": 41800828, "priceToBook": 2.0, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1627020000000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683871418, "regularMarketDayHigh": 0.074, "regularMarketDayRange": "0.074 - 0.074", "regularMarketDayLow": 0.074, "regularMarketVolume": 503, "regularMarketPreviousClose": 0.074, "bid": 0.0785, "ask": 0.098, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.074, "averageDailyVolume3Month": 48, "averageDailyVolume10Day": 107, "fiftyTwoWeekLowChange": 0.0365, "fiftyTwoWeekLowChangePercent": 0.9733333, "fiftyTwoWeekRange": "0.0375 - 0.112", "fiftyTwoWeekHighChange": -0.038000003, "fiftyTwoWeekHighChangePercent": -0.33928573, "fiftyTwoWeekLow": 0.0375, "fiftyTwoWeekHigh": 0.112, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "symbol": "7JN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Queen Mary BioEnterprises Innovation Ctr", "address2": "42 New Road", "city": "London", "zip": "E1 2AX", "country": "United Kingdom", "phone": "44 20 7183 1499", "website": "https://www.poolbegpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in\u00adlicensed first\u00adin\u00adclass broad spectrum RNA\u00adbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro\u00ad and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Skillington Ph.D.", "title": "CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ian  O'Connell", "title": "CFO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Carol  Dalton", "title": "VP of Investor Relations & PR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Salim  Hamir F.C.A.", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ross  Crockett", "title": "Group Financial Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}